AR antagonists such as ENZ have been found to cross the blood-brain-barrier; thus, their antitumoral potential in GBM has been investigated, revealing that antiandrogens slow down the growth and radiosensitize AR-positive GBM cell lines and xenografts [44]. This evidence concerns the gene AR and glioblastoma.